| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.1986.TB51250.X |
| P698 | PubMed publication ID | 3010788 |
| P50 | author | Philip Cowen | Q55446285 |
| P2093 | author name string | Cowen PJ | |
| P2860 | cites work | Neuroendocrine markers of CNS drug effects | Q34518891 |
| Mechanism of the antidepressant action of electroconvulsive therapy | Q39472392 | ||
| Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses. | Q41533213 | ||
| Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks | Q48280763 | ||
| The effects of acute and repeated administration of various antidepressant drugs on clonidine-induced hypoactivity in mice and rats | Q48770706 | ||
| Up- and down-regulation of central postsynaptic ?2 receptors reflected in the growth hormone response to clonidine in reserpine-pretreated rats | Q49106543 | ||
| Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanism of action of ECT. | Q49125373 | ||
| Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents | Q49159864 | ||
| Effect of clonidine on growth hormone release in psychiatric patients and controls | Q52105073 | ||
| Effect of apomorphine on human-growth-hormone secretion. | Q53782442 | ||
| Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. | Q54525200 | ||
| Adrenergic Blockade and the Corticosteroid and Growth Hormone Responses to Methylamphetamine | Q59076362 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 163-171 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Neuroendocrine responses as a probe into the mechanisms of action of electroconvulsive therapy | |
| P478 | volume | 462 |
| Q68476516 | Electroconvulsive Therapy in the Treatment of Combined Depression and Parkinson's Disease | cites work | P2860 |
Search more.